Edenbridge Pharmaceuticals, LLC
Edenbridge Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing, and marketing prescription pharmaceutical products. Edenbridge is excited to present Hemady (dexamethasone) 20 mg tablets to attendees of the 2023 ASH Annual Meeting. Hemady is a corticosteroid indicated in combination with other anti-myeloma products for the treatment of adults with multiple myeloma. Hemady is the first FDA-approved dexamethasone for the treatment of multiple myeloma.